{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:45:35Z","timestamp":1772329535046,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.semerg.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T03:50:38Z","timestamp":1419047438000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recomendaciones de buena pr\u00e1ctica en el tratamiento de la dislipemia en la diabetes"],"prefix":"10.1016","volume":"41","author":[{"given":"A.","family":"Hormigo-Pozo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mancera-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Perez-Unanua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alonso-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lopez-Simarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Mediavilla-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2014.11.007_bib0210","unstructured":"IDF Diabetes Atlas-International Diabetes Federation [consultado 12 Oct 2014]. Disponible en: htpp:\/\/www.idf.org\/diabetesatlas"},{"key":"10.1016\/j.semerg.2014.11.007_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","article-title":"Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study","volume":"55","author":"Soriguer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.semerg.2014.11.007_bib0015","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.semerg.2014.11.007_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2014.11.007_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/HJR.0b013e32833ba61e","article-title":"Blood lipids in 75,048 type 2 diabetic patients: A population-based survey from the Swedish National diabetes register","volume":"18","author":"Eriksson","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"10.1016\/j.semerg.2014.11.007_bib0030","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/dc11-1679","article-title":"Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain)","volume":"35","author":"Vinagre","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semerg.2014.11.007_bib0035","unstructured":"N\u00fa\u00f1ez-Cort\u00e9s JM, Diaz A, Blasco M, Perez F, coordinadores. Gu\u00eda cl\u00ednica para la detecci\u00f3n, diagn\u00f3stico y tratamiento de la dislipemia aterog\u00e9nica en atenci\u00f3n primaria [consultado 8 Oct 2014]. Disponible en: http:\/\/www.semergen.es\/semergen\/catalogo-editorial\/guia-clinica-para-la-deteccion-diagnostico-y-tratamiento-de-la-dislipemia"},{"key":"10.1016\/j.semerg.2014.11.007_bib0040","first-page":"1","article-title":"Dislipemia, diabetes tipo 2 y enfermedad renal. Aspectos fisiopatol\u00f3gicos y terap\u00e9uticos","volume":"17","author":"Travesera","year":"2009","journal-title":"Separata Linea Montpellier"},{"key":"10.1016\/j.semerg.2014.11.007_bib0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semerg.2010.07.006","article-title":"Determinaciones anal\u00edticas en el paciente diab\u00e9tico","volume":"36","author":"L\u00f3pez-Simarro","year":"2010","journal-title":"Semergen."},{"key":"10.1016\/j.semerg.2014.11.007_bib0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.medcli.2013.03.016","article-title":"Dislipidemia aterog\u00e9nica en pacientes con diabetes mellitus tipo 1","volume":"141","author":"Chillar\u00f3n","year":"2013","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.semerg.2014.11.007_bib0055","first-page":"19C","article-title":"Riesgo elevado de disfunci\u00f3n lipoproteica en la diabetes mellitus tipo 2","volume":"8","author":"Carmena","year":"2008","journal-title":"Rev Esp Cardiol Supl."},{"key":"10.1016\/j.semerg.2014.11.007_bib0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40265-013-0023-5","article-title":"Dyslipidemia in type 2 diabetes: Prevalence, pathophysiology, and management","volume":"73","author":"Chehade","year":"2013","journal-title":"Drug"},{"key":"10.1016\/j.semerg.2014.11.007_bib0065","first-page":"299","article-title":"Dislipidemia diab\u00e9tica, macro y microangiopat\u00eda","volume":"24","author":"Pedro-Botet","year":"2012","journal-title":"Clin Invest Arterioscl."},{"key":"10.1016\/j.semerg.2014.11.007_bib0215","unstructured":"National Institute for Health and Clinical Excellence. NICE clinical guideline 181. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. Julio 2014 [consultado 15 Oct 2014]. Disponible en: http:\/\/www.nice.org.uk\/guidance\/cg181"},{"key":"10.1016\/j.semerg.2014.11.007_bib0075","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.semerg.2014.11.007_bib0080","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/eurheartj\/ehr035","article-title":"Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: A meta-analysis of >40 000 patients","volume":"32","author":"Mills","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2014.11.007_bib0085","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2014.11.007_bib0090","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J."},{"issue":"Suppl 1","key":"10.1016\/j.semerg.2014.11.007_bib0095","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.jcjd.2013.01.032","article-title":"Dyslipidemia","volume":"37","author":"Mancini","year":"2013","journal-title":"Can J Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.semerg.2014.11.007_bib0100","first-page":"S1","article-title":"Standard of medical care in diabetes 2014","volume":"37","year":"2014","journal-title":"Diabetes Care."},{"issue":"25 Pt B","key":"10.1016\/j.semerg.2014.11.007_bib0105","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.semerg.2014.11.007_bib0110","first-page":"9","article-title":"Estatinas en la prevenci\u00f3n primaria de la enfermedad cardiovascular en pacientes con diabetes tipo 2","volume":"2","author":"Rodr\u00edguez Poncelas","year":"2011","journal-title":"Diabetes Pr\u00e1ctica"},{"key":"10.1016\/j.semerg.2014.11.007_bib0115","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00125-009-1454-0","article-title":"Cardiovascular risk assessment scores for people with diabetes: A systematic review","volume":"52","author":"Chamnan","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.semerg.2014.11.007_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jech.2005.038505","article-title":"Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study","volume":"61","author":"Marrugar","year":"2007","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.semerg.2014.11.007_bib0125","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination or perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2014.11.007_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-1725","article-title":"Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial","volume":"160","author":"Salas-Salvad\u00f3","year":"2014","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.semerg.2014.11.007_bib0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2014.11.007_bib0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-147-6-200709180-00005","article-title":"Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: A randomized trial","volume":"147","author":"Sigal","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.semerg.2014.11.007_bib0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering, LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials","volume":"380","year":"2012","journal-title":"Lancet."},{"issue":"Supl 1","key":"10.1016\/j.semerg.2014.11.007_bib0225","first-page":"1","article-title":"Abordaje de la dislipemia en pacientes con diabetes tipo 2","volume":"38","author":"D\u00edaz Rodr\u00edguez","year":"2012","journal-title":"Semergen"},{"key":"10.1016\/j.semerg.2014.11.007_bib0230","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/M13-2526","article-title":"Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: A systematic review","volume":"160","author":"Gudzune","year":"2014","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.semerg.2014.11.007_bib0235","first-page":"242","article-title":"Control del colesterol LDL en pacientes de muy alto riesgo vascular. Algoritmo simplificado para alcanzar objetivos de colesterol LDL \u00aben dos pasos\u00bb","volume":"26","author":"Guijarro-Herraiz","year":"2014","journal-title":"Clin Invest Arterioscl."},{"key":"10.1016\/j.semerg.2014.11.007_bib0240","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1463-1326.2011.01383.x","article-title":"Lipid-altering efficacy and safety profile of combination therapy with ezetimibe\/statin vs. statin monotherapy in patients with and without diabetes: An analysis of pooled data from 27 clinical trials","volume":"13","author":"Leiter","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.semerg.2014.11.007_bib0245","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J."},{"key":"10.1016\/j.semerg.2014.11.007_bib0250","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.amjcard.2013.02.005","article-title":"Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial)","volume":"111","author":"Maron","year":"2013","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.semerg.2014.11.007_bib0255","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2014.11.007_bib0260","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.semerg.2014.11.007_bib0265","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2014.11.007_bib0270","first-page":"193","article-title":"Vencer la inercia terap\u00e9utica en el manejo del paciente dislip\u00e9mico: Un reto en la pr\u00e1ctica cl\u00ednica diaria","volume":"26","author":"Morales","year":"2014","journal-title":"Clin Invest Arterioscl."},{"key":"10.1016\/j.semerg.2014.11.007_bib0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.medcli.2011.07.023","article-title":"Inertia and treatment compliance in patients with type 2 diabetes in primary care","volume":"138","author":"L\u00f3pez-Simarro","year":"2012","journal-title":"Med Clin (Barc)"}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359314004754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359314004754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T16:54:53Z","timestamp":1566147293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359314004754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1138359314004754"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2014.11.007","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones de buena pr\u00e1ctica en el tratamiento de la dislipemia en la diabetes","name":"articletitle","label":"Article Title"},{"value":"SEMERGEN - Medicina de Familia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}